Bryn Mawr Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-320
| Closed | -$203K | – | 429 |
|
|
2025
Q1 | $203K | Buy |
+320
| New | +$203K | 0.01% | 374 |
|
|
2018
Q1 | – | Sell |
-11,542
| Closed | -$5.16M | – | 92 |
|
|
2017
Q4 | $5.16M | Hold |
11,542
| – | – | 6.77% | 3 |
|
|
2017
Q3 | $5.16M | Hold |
11,542
| – | – | 5.37% | 4 |
|
|
2017
Q2 | $5.67M | Sell |
11,542
-78
| -0.7% | -$38.3K | 6.39% | 4 |
|
|
2017
Q1 | $4.5M | Buy |
+11,620
| New | +$4.5M | 4.63% | 4 |
|